Chronic Heart Failure Updates at ACC 2022: Important New Findings for HFrEF and HFpEF *

April 2-4, 2022; Washington, DC
Review the latest data in managing HFrEF and HFpEF with a Capsule Summary and expert-authored commentaries covering key studies and updates from ACC 2022.

Share

Program Content

2 Capsule Summary Slidesets

Activities

PARAGON-HF
PARAGON-HF: Sacubitril/Valsartan vs Valsartan in Patients With and Without Diabetes and Heart Failure With Preserved Ejection Fraction
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 06, 2022

Expires: April 05, 2023

SODIUM-HF
SODIUM-HF: Low-Sodium Dietary Intervention in Heart Failure Patients
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 06, 2022

Expires: April 05, 2023

Activities

New Data in HFrEF
Expert Insights From ACC 2022: How New Data in HFrEF Could Influence Your Practice
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: April 20, 2022

Expires: April 19, 2023

New Data in HFpEF
ACC 2022: Expert Analysis of New Data in HFpEF
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: April 26, 2022

Expires: April 25, 2023

New HF Guidelines
New and Noteworthy: An Expert’s Take on the 2022 AHA/ACC/HFSA Heart Failure Guidelines
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: May 10, 2022

Expires: May 09, 2023

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from

Merck Sharp & Dohme Corp.

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.